"Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —I"
written by Noriyasu Seki, Yasuhiro Maeda, Hirotoshi Kataoka, Kunio Sugahara, Kenji Chiba,
published by Pharmacology & Pharmacy, Vol.4 No.8, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
Molecular imaging, 2018
[2] Znaczenie kinazy sfingozyny-1 oraz sfingozyno-1-fosforanu w doświadczalnym modelu choroby Parkinsona oraz w farmakologicznej cytoprotekcji
Thesis, 2017
[3] Sphingolipids as a new factor in the pathomechanism of preeclampsia–Mass spectrometry analysis
PLOS ONE, 2017
[4] PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Molecular Imaging and Biology, 2016
[5] Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry, 2016
[6] IL-17–Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory …
2015
[7] IL-17–Producing Vg4 gd T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory …
2015
[8] IL-17–Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
The Journal of Immunology, 2015
[9] IL-17–Producing Vg4 gd T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
2015
[10] An update on the biology of sphingosine 1-phosphate receptors
Journal of lipid research, 2014
[11] Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
2014